In AD, aggregation of the Aβ peptide in particular seems to initiate a cascade of detrimental events including the hyperphosphorylation and accumulation of tau, inflammatory activation, and synaptic and neuronal dysfunction and loss. The gene discussed is MAPT; the disease is Alzheimer disease.